Global Peripheral Stent Graft Market Size By Type (AAA Stent Graft, TAA Stent Graft), By Application (Lower Limb Surgical Graft, Aorta Repair Surgical Graft), By Region, And Segment Forecasts, 2023 to...

The Global Peripheral Stent Graft Market was valued at USD 1.34 billion in 2023 and is projected to reach USD 2.47 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2023–2031). The market is witnessing substantial growth driven by the rising prevalence of peripheral artery disease (PAD), increasing geriatric population, and advancements in minimally invasive endovascular procedures. Peripheral stent grafts, used to reinforce blood vessel walls and maintain proper blood flow, are gaining traction due to their efficacy in treating aneurysms and blocked arteries, especially in lower limbs.

Drivers:

1. Growing Burden of Peripheral Artery Disease (PAD):

Rising incidences of PAD globally, especially among older populations and diabetics, are a key growth driver. PAD leads to narrowed arteries that reduce blood flow to the limbs, and stent grafts provide a critical solution in managing this condition.

2. Advancements in Endovascular Technologies:

The evolution of stent graft design, materials, and delivery systems has made procedures less invasive with better clinical outcomes, encouraging wider adoption.

3. Aging Population and Lifestyle Factors:

An aging global population, combined with increasing obesity and smoking rates, is contributing to a higher prevalence of vascular disorders, thereby boosting market demand.

Restraints:

1. High Cost of Treatment:

Peripheral stent graft procedures, including devices and hospital stays, remain costly, which may limit adoption in cost-sensitive healthcare markets, especially in low-income countries.

2. Risk of Complications and Restenosis:

Although generally safe, stent grafts can occasionally lead to complications like thrombosis, graft migration, or restenosis, which can deter physicians from recommending them in some cases.

Opportunity:

1. Growth in Emerging Markets:

Rapid healthcare infrastructure development and improving access to medical treatments in Asia-Pacific and Latin America present significant opportunities for market expansion.

2. Technological Integration with Imaging & Robotics:

Integration with real-time imaging, robotic-assisted surgery, and AI-guided interventions is opening new frontiers in accuracy and patient-specific treatments.

Market by System Type Insights:

Covered Stent Grafts held the largest market share in 2023 due to their superior strength, durability, and adaptability in complex vascular anatomies. These stents are widely used for both aneurysm repair and revascularization procedures. Uncovered/Bare Metal Stents are still used in select indications but are experiencing declining demand due to higher restenosis rates.

Market by End-use Insights:

Hospitals & Surgical Centers dominated the market in 2023, owing to the availability of advanced infrastructure and skilled vascular surgeons. However, Ambulatory Surgical Centers (ASCs) are expected to witness the highest growth rate during the forecast period due to the rising demand for same-day, cost-effective peripheral vascular interventions.

Market by Regional Insights:

North America accounted for the largest revenue share in 2023, attributed to a high prevalence of PAD, favorable reimbursement scenarios, and early adoption of advanced technologies. Asia-Pacific, particularly China and India, is anticipated to be the fastest-growing region during the forecast period, fueled by increasing healthcare investments and rising awareness about peripheral vascular diseases.

Competitive Scenario:

Key players in the global peripheral stent graft market include Medtronic plc, W. L. Gore & Associates, Cook Medical, BD (Becton, Dickinson and Company), Terumo Corporation, Abbott Laboratories, and Boston Scientific Corporation. These companies are focusing on innovations, regulatory approvals, and strategic partnerships. For example:

In 2024, W. L. Gore received expanded FDA approval for its Viabahn stent graft for new PAD indications.

In 2023, Medtronic launched a next-generation self-expanding stent graft system with enhanced trackability and lower profile for easier navigation in complex vascular anatomies.

Scope of Work – Global Peripheral Stent Graft Market:

Report Metric Details

Market Size (2023) USD 1.34 billion

Projected Market Size (2031) USD 2.47 billion